Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

pathophys > Hemostasis > Flashcards

Hemostasis Flashcards

1
Q
  1. What is the cause of thrombocytopenia in liver cirrhosis?
    Select one:
    a. decreased bile secretion
    b. direct effect of metabolic alterations on the bone marrow
    c. splenomegaly – hypersplenia
    d. hyperbilirubinemia
    e. malabsorption
A

C

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q 
2. Vitamin K dependent coagulation factors:
Select one or more:
a. Stuart-Prower factor (X)
b. fibrinogen (I)
c. Christmas factor (IX)
d. prothrombin (II)
A

AC//D

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q
  1. Which of the following statements is true regarding the regulation of platelet production?
    Select one:
    a. Hypoxemia is an important stimulus of platelet production.
    b. The stimulating hormone, thrombopoietin is produced in the bone marrow.
    c. No hormone is known to inhibit platelet production.
    d. The segmented nuclei of the megakaryocytes are incorporated in the platelets.
    e. Platelet production is decreased in inflammation.
A

A

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q 
4. Direct interaction partner of thrombin, except:
Select one:
a. subendothelial smooth muscle cells
b. platelets
c. lymphocytes
d. monocytes
e. endothelial cells
A

A

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q 
5. Surface receptor that plays a role in platelet activation:
Select one:
a. prostacyclin
2.719.0
b. histidine decarboxylase
c. thromboxane A2
d. glycoprotein IIb/IIIa
e. endocannabinoid
A

D

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q
  1. Laboratory alteration suggesting deep vein thrombosis:
    Select one or more:
    a. decreased erythrocyte sedimentation rate (ESR)
    b. decreased hemoglobin level
    c. decreased activated partial thromboplastin time (aPTT)
    d. elevated plasma D-dimer level
A

D

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q 
7. Acquired risk factor for deep vein thrombosis:
Select one or more:
a. dehydration
b. nephrotic syndrome
c. hypertension
d. obesity
A

A/B/D

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q 
8. Endothelial cells synthesize:
Select one:
a. prostaglandin E2
b. serotonin
c. protein C
d. von Willebrand factor
e. elastase
A

D

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q 
9. Thrombocytopenia can occur, except in:
Select one:
a. acute leukemia
b. in autoimmune disease
c. following massive transfusion
d. acute inflammation
e. in measles infection
A

D

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q 
9. Thrombocytopenia can occur, except in:
Select one:
a. acute leukemia
b. in autoimmune disease
c. following massive transfusion
d. acute inflammation
e. in measles infection
A

A

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q 
10. Coagulation factors with serine protease activity:
Select one or more:
a. Stuart-Prower factor (X)
b. fibrin stabilizing factor (XIII)
c. anti-hemophilic factor (VIII)
d. von Willebrand factor
A

E

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q 
11. Its concentration increases in inflammation:
Select one:
a. protein C
b. factor X (Stuart-Prower)
c. thrombomodulin
d. factor II (prothrombin)
e. factor VIII (anti-hemophilic)
A

E

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q
  1. Laboratory alterations in disseminated intravascular coagulation (DIC):
    Select one or more:
    a. decreased activated partial thromboplastin time (aPTT)
    b. prolonged thrombin time (TT)
    c. elevated D-dimer level
    d. decreased fibrinogen level
A

B/C/D

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q
  1. Laboratory alterations in disseminated intravascular coagulation (DIC):
    Select one or more:
    a. decreased activated partial thromboplastin time (aPTT)
    b. prolonged thrombin time (TT)
    c. elevated D-dimer level
    d. decreased fibrinogen level
A

C

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q 
15. Vitamin K dependent coagulation factor, except:
Select one:
a. factor VIII (anti-hemophilic)
b. factor II (prothrombin)
c. factor X (Stuart-Prower)
d. factor IX (Christmas)
e. factor VII (proconvertin)
A

A

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q 
16. Characteristics in hemophilia type B:
Select one or more:
a. deficiency of factor VIII
b. bleedings in joints and muscles
c. deficiency of factor IX
d. autosomal recessive inheritance
A

B/D

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q 
15. Vitamin K dependent coagulation factor, except:
Select one:
a. factor VIII (anti-hemophilic)
b. factor II (prothrombin)
c. factor X (Stuart-Prower)
d. factor IX (Christmas)
e. factor VII (proconvertin)
A

A

18
Q 
16. Characteristics in hemophilia type B:
Select one or more:
a. deficiency of factor VIII
b. bleedings in joints and muscles
c. deficiency of factor IX
d. autosomal recessive inheritance
A

B/C

19
Q 
17. Mechanism of bleeding of vascular origin, except:
Select one:
a. amyloidosis
b. hypertension
c. immuncomplex deposition
d. connective tissue atrophy
e. altered TGF-β signaling
A

B

20
Q 
18. Anticoagulation mechanisms/factors:
Select one or more:
a. prostacyclin
b. antithrombin III
c. protein S
d. heparin cofactor type II
A

A/B/C/D

21
Q
  1. Thrombotic thrombocytopenic purpura (TTP) is characterized by:
    Select one or more:
    a. ADAMTS13 deficiency
    b. increased platelet aggregation
    c. von Willebrand factor protein of ultra large size
    d. renal failure
A

A/B/C

22
Q 
20. Anticoagulation mechanisms/factors:
Select one or more:
a. protein C
b. thrombomodulin
c. thromboxane A2
d. dilution
A

A/B/D

23
Q 
21. Characteristics in hemophilia type A:
Select one or more:
a. deficiency of factor VIII
b. mucous membrane and skin bleedings
c. males are affected
d. deficiency of factor IX
A

A/B/C

24
Q 
22. Their concentration increases in inflammation:
Select one or more:
a. anti-hemophilic factor (VIII)
b. fibrinogen (I)
c. prothrombin (II)
d. free fatty acids
A

A/B

25
Q
  1. Major therapeutic methods in disseminated intravascular coagulation (DIC):
    Select one or more:
    a. anti-thrombotic treatment
    b. raising of the blood pressure
    c. supplementation of coagulation factors
    d. vitamin K supplementation
A

A/C

26
Q
  1. Laboratory alterations in disseminated intravascular coagulation (DIC):
    Select one or more:
    a. decreased platelet number
    b. elevated fibrinogen level
    c. decreased hemoglobin level
    d. prolonged activated partial thromboplastin time (aPTT
A

A/D

27
Q 
25. Disseminated intravascular coagulation (DIC) can be caused by the following, except:
Select one:
a. septic abortion
b. polytraumatic state
c. acute promyelocytic leukemia (APL)
d. pancreatitis
e. hypertension crisis
A

E

28
Q
  1. Platelet production can be inhibited by:
    Select one:
    a. vitamin B12 deficiency
    b. all answers are correct
    c. chemotherapy
    d. bone marrow manifestation of malignant disease
    e. measles virus infection
A

B

29
Q
  1. Platelet production can be inhibited by:
    Select one:
    a. vitamin B12 deficiency
    b. all answers are correct
    c. chemotherapy
    d. bone marrow manifestation of malignant disease
    e. measles virus infection
A

B

30
Q
  1. Idiopathic thrombocytopenic purpura (ITP) is characterized by:
    Select one:
    a. it is associated with vitamin K deficiency
    b. decreased platelet aggregation
    c. it is more common in females than males
    d. decreased platelet release reaction
    e. bleedings into the joints
A

C

31
Q
  1. Major indications of routine laboratory coagulation testing:
    Select one or more:
    a. bleeding tendency in a genetically related family member
    b. skin bleeding
    c. preparation for surgery
    d. long term febrile states
A

A/B/C

32
Q
  1. Which of the following statements are true regarding antithrombin III deficiency:
    Select one or more:
    a. An important anticoagulant mechanism is missing.
    b. Direct thrombin inhibition is altered.
    c. It is more common than the Leiden mutation.
    d. Its main manifestation is deep vein thrombosis.
A

A/B/D

33
Q
  1. Typical laboratory results in vitamin K antagonist treatment:
    Select one or more:
    a. normal activated partial thromboplastin time (aPTT)
    b. normal prothrombin time (PT)
    c. normal platelet count
    d. prolonged thrombin time (TT)
A

C

34
Q 
31. Acquired coagulation factor deficiency can occur:
Select one or more:
a. in chronic pancreatitis
b. in liver cirrhosis
c. in diabetes mellitus type I
d. in heart valve insufficiency
A

B

35
Q 
32. Acquired risk factors for deep vein thrombosis:
Select one or more:
a. sustained immobilization
b. overdose of vitamin K
c. asthma bronchiale
d. malignant disease
A

A/D

36
Q
  1. Potential mechanism of bleedings due to vascular alterations, except:
    Select one:
    a. mechanical injury
    b. inflammation affecting the small vessels
    c. weakening of the vessel wall connective tissue
    d. immuncomplex deposition
    e. atherosclerosis
A

E

37
Q
  1. Bleeding due to coagulation factor deficiency is characterized:
    Select one:
    a. First manifestation may be gingival bleeding.
    b. Its prevalence is the same in both genders.
    c. Frequent association with skin bleeding.
    d. Deeper localization, in the joints.
    e. It is more common in women.
A

D

38
Q 
35. Interaction partner of thrombin:
Select one:
a. lymphocytes
b. monocytes
c. fibrinogen
d. platelets
e. all the answers are correct
A

E

39
Q
  1. Streptokinase affects:
    Select one:
    a. kallikrein activation
    b. thrombin inactivation
    c. enhancement of antithrombin III effect
    d. conversion of plasminogen to plasmin
    e. inhibition of fibrinogen binding of thrombin
A

D

40
Q
  1. Streptokinase affects:
    Select one:
    a. kallikrein activation
    b. thrombin inactivation
    c. enhancement of antithrombin III effect
    d. conversion of plasminogen to plasmin
    e. inhibition of fibrinogen binding of thrombin
A

D

pathophys (17 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions